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Genes of the major histocompatibility complex (MHC) play a critical role in immune recognition, and many 
alleles confer susceptibility to infectious and autoimmune diseases. How these deleterious alleles persist in 
populations is controversial. One hypothesis postulates that MHC heterozygote superiority emerges over 
multiple infections because MHC-mediated resistance is generally dominant and many allele-specific suscep­
tibilities to pathogens will be masked by the resistant allele in heterozygotes. We tested this hypothesis by using 
experimental coinfections with Salmonella enterica (serovar Typhimurium C5TS) and Theiler's murine enceph­
alomyelitis virus (TMEV) in MHC-congenic mouse strains where one haplotype was resistant to Salmonella and 
the other was resistant to TMEV. MHC heterozygotes were superior to both homozygotes in 7 out of 8 
comparisons (P =  0.0024), and the mean standardized pathogen load of heterozygotes was reduced by 41% over 
that of homozygotes (P =  0.01). In contrast, no heterozygote superiority was observed when the MHC haplotype 
combinations had similar susceptibility profiles to the two pathogens. This is the first experimental evidence 
for MHC heterozygote superiority against multiple pathogens, a mechanism that would contribute to the 
evolution of MHC diversity and explain the persistence of alleles conferring susceptibility to disease.
Major histocompatibility complcx (MHC) genes arc the 
most diverse genes known. One of the postulated mechanisms 
for maintaining this diversity is MHC hctcrozygotc superiority, 
or ovcrdominancc. The phrase hctcrozygotc advantage (7, 12) 
is often used as a synonym for hctcrozygotc superiority but is 
also used for other meanings (36, 38). In population studies, it 
is used in the general sense to imply that the mean fitness of 
heterozygotes is higher than the mean fitness of all homozy­
gotes (8, 47). In laboratory studies and evolutionary models, it 
is often used in the narrow sense to imply that heterozygotes 
arc superior to both parental homozygotes (46). To avoid this 
confusion, wc have defined hctcrozygotc advantage to mean 
that the hctcrozygotc is better than the average of both ho- 
mozygotcs and wc have defined hctcrozygotc superiority to 
mean that the hctcrozygotc is better than both homozygotes 
(ovcrdominancc) (36). This distinction is important bccausc 
hctcrozygotc advantage by itself cannot contribute to MHC 
diversity, whereas hctcrozygotc superiority can (46).
For any given autoimmune or infectious disease, some MHC 
alleles arc usually found that confer susceptibility (3, 47). It is 
unclcar what keeps these demonstrably harmful genes from 
being eliminated by natural selection. Some form of balancing 
and diversifying selection must be operating consistently over 
long periods of evolutionary time to explain the relatively 
unique and extreme features of MHC diversity (2). This MHC 
diversity is generally thought to result from pathogen-mediated 
selection, through either hctcrozygotc superiority or antago­
nistic host-pathogcn cocvolution (7, 17). Both mechanisms fa­
vor rare and new alleles (selection for divergence) and also
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maintain large numbers of alleles bccausc allclic extinction 
rates arc rcduccd. Moreover, both mechanisms predict the 
cxistcncc of some MHC alleles (or genotypes) that confer 
susceptibility to certain diseases. In the ease of hctcrozygotc 
superiority, low-fitncss homozygotes will express a susceptible 
phenotype. In the ease of antagonistic cocvolution, MHC al­
leles that have been the target of recent pathogen evasion 
(evolution) will be susceptible.
MHC heterozygotes arc cxpcctcd to be superior to both 
homozygotes bccausc they can present a wider variety of pep­
tide antigens to T lymphocytes (12), the triggering event of the 
adaptive immune response (51). Although this is the mecha­
nistic explanation generally given for hctcrozygotc superiority, 
single-infection experiments do not support this hypothesis: 
heterozygotes arc usually similar to the resistant homozygotc 
but arc seldom better (2). This is not surprising, since most 
immune responses arc dominated by T-ccll recognition of one 
or a few MHC-prcscntcd peptides (immunodominance) (54) 
rather than all or most of the presented peptides. Therefore, 
presentation of more peptide antigens by MHC heterozygotes 
may have little effect on the immune recognition of pathogens.
Still, hctcrozygotc superiority is cxpcctcd to emerge after 
serial or simultaneous coinfections (12, 24) when resistance is 
dominant and the susceptibility profiles of two pathogens arc 
opposite or reciprocal (39). Wc will refer to this as the dual­
infection hctcrozygotc superiority (DIHS) hypothesis. Hct- 
crozygotcs should be superior under these two conditions bc­
causc, for any pathogen, the susceptibility of the worst allele 
would be masked by the resistant allele (Fig. I). In fact, the 
literature docs indicate that MHC-mcdiatcd resistance to in­
fections is generally dominant (63% of 49 haplotypc-pathogcn 
combinations tested and 79% of 13 pathogens tested) (Table 
I). Resistance being dominant provides a mechanistic basis for 
how MHC hctcrozygotc superiority can occur during dual in­
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FIG. 1. Hypothetical MHC-associated pathogen loads for three pathogens and the predicted combined pathogen loads during different dual 
infections. M IIC genotypes infected with single pathogens (a. b. and c) show different patterns of susceptibility. Combined pathogen loads during 
dual infections (d and e) are obtained by adding the single pathogen loads for each genotype and standardizing the axes. W hen animals are infected 
with two pathogens that show opposite susceptibility profiles (a and b). heterozygotes are predicted to be superior (d). W hen animals are infected 
with two pathogens that show similar susceptibility profiles (a and c). heterozygotes are predicted to be intermediate (e). MHC-mediated resistance 
is dominant in all cases and is required for the predicted patterns (2 ).
immunodominance generally favors T-cell responses associ­
ated with the more-resistant allele (though this mechanism is 
not yet characterized) (54).
Therefore, the critical empirical test of the DIHS hypothesis 
requires resistance to be dominant in experimental dual infec­
tions with pathogens and MHC combinations that show both 
opposite (Fig. Id) and similar susceptibility profiles (Fig. le,
negative control). If MHC haplotypes confer opposite patterns 
of susceptibility (Fig. la  and b), then heterozvgotes should be 
superior when infected by both pathogens (Fig. Id). However, 
if MHC haplotypes confer similar patterns of susceptibility 
(Fig. la  and c), then heterozvgotes should be intermediate 
between the two homozvgotes (Fig. le).
In this study, we provide the first experimental test of the
TABLE 1. Survey of published literature to determine if M HC-dependent resistance is dominant or recessive'7
Infectious agent Assay MHC heterozygote(s) Resistance Reierence(s)
Mouse hepatitis virus Paralysis blf Dominant 27
Cytomegalovirus Survival bid, b/k, dlk Dominant 16
Theiler's virus Spinal cord viral titer b lq jlk Dominant This study
dlk, d/q females Dominant
dlk, d/q males Recessive
Demyelination blf, blr, dlf, flk Dominant 35
Bacteriophage fd Antibody response Dw Recessive 25
dlk, b/k Dominant
Murine AIDS retrovirus Disease severity a/b, b/d, b/k Recessive 29
Friend virus Spleen focus formation a/b, a/i5, b/d, li4H5 Recessive 50
Recovery
High dose b/k Recessive 33
Low dose b/k Dominant
Vaccinated b/k Dominant
Murine leukemia virus Virus titer a/b Recessive 48
a/b Dominant 31
b/pa Dominant 1 1
Antibody response b/d, b/a Dominant 49
Survival D'» Dominant 32
Salmonella enterica (serovar Bacterial titer b/q Dominant This study
Typhimurium C5TS) d/k, d/q, fIk males Dominant
d/k, d/q, fIk females Recessive
Streptococcus pyogenes Hepatic granuloma formation b/d, dlk Dominant 10
b/k Recessive
Leishmania donovani Parasitemia b/d Recessive 6
Schistosoma mansoni Parasitemia b/k Dominant 45
Trypanosoma e n d Parasitemia b/s females Dominant 52, 53
b/s males Recessive
Trichuris mtiris Worm burden k/q Dominant 13
Ileligmosomoides polygyrtis Worm burden b/k, dlk, slk Dominant 4
“ This table provides a survey of the literature to evaluate whether MHC-dependent resistance shows dominant or recessive patterns of inheritance. The literature 
was accumulated by using previous reviews (2, 36) as well as MedLine searches with the following keywords in various combinations: MIIC, II-2*, congenic, Fl, 
resistance, susceptibility, dominant, and susceptib* (where * returns all possible endings). To be included, a study had to use MHC-congenic animals (a necessary 
condition not completely followed in previous results [2, 36]) in an infection model where heterozygotes and both homozygotes were evaluated. Resistance of a 
particular MHC haplotypic combination was scored as dominant when the heterozygote was more like the best than the worst homozygote. If the converse was true, 
it was scored as recessive. If an MHC heterozygote was assayed more than once with the same result, it was only counted once for summary statistics (secondary accounts 
are underlined). When each haplotype was counted, resistance was dominant in 63% of the 49 haplotype-pathogen combinations tested. If each pathogen was scored 
as either dominant or recessive, dependent on the majority pattern (ties are excluded), then resistance was dominant 79% of the time (10 out of 13 pathogens). 
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DIHS hypothesis by coinfection with the pathogens Salmonella 
enterica (serovar Typhimurium C5TS) and Theilefs murine 
encephalomyelitis virus (TMEV). Although serial infections 
are generally more common in nature, coinfections represent a 
potentially important case in which MHC-dependcnt escape 
variants emerge (causing different susceptibility profiles) dur­
ing the course of single infections, as seen for diversifying 
pathogens such as human immunodeficiency virus (HIV) (30), 
simian immunodeficiency virus (1), hepatitis B (5), hepatitis C 
(14), and human T-cell leukemia virus (15). We demonstrate 
that MHC heterozygote superiority emerges when resistance is 
dominant and MHC haplotypic combinations have susceptibil­
ity profiles that are opposite. These results provide a mecha­
nism that could help explain the unprecedented diversity of 
MHC genes and the persistence of MHC alleles which confer 
disease susceptibility.
MATERIALS AND METHODS
Mice. MHC-congenic mice (C57BL/10SnJ-//2fo, B10.D2-H2a, BlO.M-ffif 
BlQ.BR-fZ2*, and B10.Q-HZ1) were obtained from Jackson Laboratories and 
bred thereafter under specific-pathogen-free conditions. In order to randomize 
any genetic mutations that have become differentially fixed in these strains of 
mice (9), the F:1 heterozygotes {hiq, djq, dik, and f/k) were intercrossed to 
produce F2 segregants, which were used for all infections. To control for poten­
tial variation among cages, mice were housed by sex in groups of six individuals 
representing the three genotypes to be compared (e.g., bib, hiq, and qiq or did, 
dlq, and qiq). All qlq and kik mice were analyzed according to their housing 
conditions and thus not pooled for analysis (e.g., qlq mice housed with hlh and hiq 
mice were analyzed only with the hiq haplotypic combination). All cagemates 
were unrelated and had not been previously housed together when infected. The 
original coinfection experiment was repeated (see in Fig. 5, experiment 2) in an 
independent experiment in which the F2 mice were housed with F:1 and P0 mice 
of the same genotype to evaluate any differences between the generations (data 
not shown for F:1 and P0). All animal use complied with federal regulations and 
the University of Utah’s Institutional Animal Care and Use Committee guide­
lines.
Pathogens. Mice were anesthetized with metofane and simultaneously in­
fected retro-orbitally with 1 X 106 CFU of the C5TS strain of S. enterica (serovar 
Typhimurium)/ml and intracerebrally with 2 X 10s PFU of the DA strain of 
TMEV/ml. The C5TS strain is a temperature-sensitive mutant strain of Salmo­
nella (22). As a control, the single infections also received a sham infection of 
phosphate-buffered saline to control for the effects of two injections. Both agents 
are natural pathogens of mice.
Salmonella loads. Mice were sacrificed 4 weeks postinfection. Salmonella loads 
were assayed from platings of homogenized spleens. Briefly, spleens were col­
lected under antiseptic conditions, immediately homogenized, and plated on 
Shigella-Salmonella agar, which was then incubated overnight at 30°C. When this 
strain was created in the early 1970s (22) with a UV screen, the authors found 
that a small (unspecified) percentage reverted to the wild-type C5 virulent strain. 
This revertant phenotype was seen in 8.7% of the mice infected in this study. To 
check for possible wild-type revertants, the spleen homogenate was also plated 
on Shigella-Salmonella agar and incubated overnight at 37°C. If more than 50% 
of the colonies of an infected mouse also grew at 37°C, then the infection was 
deemed to be dominated by a revertant and the data point was excluded on the 
basis that the revertant was more lethal (i.e., faster replication rate than C5TS). 
Thus, comparing mortality or pathogen loads between animals that did or did not 
contain a revertant would be inappropriate. A total of 205 (out of 1,061) animals 
were excluded either because they died or were sacrificed prior to day 28 postin­
fection or because they contained Salmonella revertants. Of the excluded mice, 
78 died early, 94 were sacrificed prior to day 28 postinfection due to severe 
illness, 31 contained revertants, and 2 were excluded due to unknown genotype. 
Of the 94 mice (8.9%) sacrificed early, 61 contained revertants. The other 33 
mice that were sacrificed early were ill due to high TMEV loads or high C5TS 
loads. For the 78 that died early (7.4%), the cause of death was probably due to 
a reversion in C5TS or high TMEV or C5TS loads. There was no association with 
MHC genotype in the excluded animals that died (or were sacrificed) early (x2 — 
4.914, P — 0.77). However, there was a significant association with MHC geno­
type in animals that contained revertants versus those that did not (x2 =20.515,
P — 0.0086). The genotype with the highest number of revertants was the most 
susceptible (bib) while the genotype with the lowest number of revertants was the 
most resistant (qiq), suggesting that the pattern may simply be due to mutation 
rate (i.e., more revertants would occur in hosts with faster pathogen replication). 
We believe this makes our results more conservative because the animals with 
the high pathogen loads were disproportionately thrown out, making differences 
smaller.
TMEV loads. TMEV loads were assayed by conducting viral plaque assays on 
brain and spinal cord homogenates (26). Briefly, brain and spinal cords were 
collected and stored in 0.5 ml of TMEV diluent (phosphate-buffered saline, 1% 
antibiotics, 1% fetal calf serum) at — 70°C until assayed. Brain and spinal cords 
were homogenized and freeze-thawed twice. Samples were then centrifuged at 
450 X g for 10 min, and the supernatant was collected. Supernatant fluid was 
then added to baby hamster kidney-21 (BHK) cells and incubated for 1 h at 37°C, 
with hand rocking every 10 to 15 min. The fluid was then aspirated off the BHK 
cells, and a 1:1 mixture of 1% agarose~2X 199 medium was added to the wells. 
Plates were incubated at 37°C for 4 days before fixation with 2.5% formalin 
followed by staining with 0.1 % crystal violet and enumeration of plaques.
Standardized combined pathogen loads. Because the actual pathogen loads of 
Salmonella and TMEV differed by at least 1 order of magnitude, we stand ardized 
the loads to make them comparable and to obtain an overall pathogen load for 
every mouse. Thus, the standardized combined pathogen load was calculated as 
follows. The mean Salmonella and TMEV loads were determined for each MHC 
genotype. For example, the Salmonella loads of each bib, hiq, and qiq mouse in 
the group were divided by the mean of the worst genotype and multiplied by 100. 
All other genotypic combinations were calculated in the same way. This was 
repeated for the TMEV loads, and then the Salmonella and TMEV percents 
were averaged for every mouse. Thus, the overall pathogen load for every mouse 
was standardized by sex and experiment, allowing all of the data to be pooled. 
This standardized combined pathogen load gives equal weight to both pathogens. 
This may not be true in relation to actual fitness impacts on the host, but at this 
point we have no way to test for possible fitness differences.
Statistics. Male and female animals were analyzed separately because they 
had significantly different pathogen loads (Fig. 2 and 3). Because sex, genotype, 
and experiment were independent (Fig. 4), a binomial distribution was used to 
test whether the results of these independent experiments showed a significant 
pattern of heterozygote superiority. Since there were three possible patterns, (i) 
overdominance (the heterozygote was better than both homozygotes), (ii) un­
derdominance (the heterozygote was worse than both homozygotes), or (iii) 
codominance (the heterozygote was intermediate between the two homozy­
gotes), a value of 1/3 was used for P (the probability of obtaining any one of the 
three patterns). All other comparisons were analyzed with the Wilcoxon rank- 
sum test, unless otherwise stated. All pathogen loads were determined without 
knowledge of the MHC genotype.
RESULTS
To verify that the MHC haplotypic combinations that we 
chose from the literature indeed showed opposite (or similar) 
susceptibility profiles, we evaluated these profiles in both single 
infections and coinfections. The results of single-infection ex­
periments with the pathogen Salmonella or TMEV arc indi­
cated in Fig. 2. MHC had a significant effect on resistance, as 
predicted from the published literature (34, 43). MHC haplo­
typic combinations (b with q, cl with q, and cl with k) showed 
opposite susceptibility profiles, whereas the MHC haplotypic 
combination (f with k) showed similar susceptibility profiles 
when comparing these two pathogens. Resistance was usually 
dominant (11 out of 16 comparisons), with some exceptions. 
These haplotypic combinations were then coinfected, and 
pathogen loads were determined 4 weeks postinfection.
Figure 3 illustrates the pathogen loads for MHC genotypes 
of coinfected mice showing either opposite (Fig. 3a and c) or 
similar (Fig. 3b and d) patterns of susceptibility. Female data 
arc depicted in Fig. 3a and b, and male data arc shown in Fig. 
3c and d. As expected, the MHC b/b and q/q genotypes show 
opposite patterns of susceptibility to Salmonella and TMEV, as 
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FIG. 2. Salmonella and TMEV loads for single infections. Pathogen loads of female (a) and male (c) animals of different M IIC heterozygote 
combinations showing opposite susceptibility profiles. Pathogen loads of female (b) and male (d) animals of different M IIC heterozygote 
combinations showing similar susceptibility profiles. In the case of opposite susceptibility profiles (a and c). all homozygotes were significantly 
different (P  < 0.05 by t test), except the following: Salmonella loads for the d/d and q/q genotypic combinations in females (P =  0.08). TMEV loads 
for the d/d and k/k  genotypic combinations in females (P  =  0.17). and TMEV loads for the d/d and k/k  genotypic combinations in males (P  =  0.08). 
Sample sizes are indicated above each bar. sped, spinal cord.
cxpcctcd, the MHC f /f  and k/k genotypes show similar patterns 
of susceptibility to these two pathogens. However, the MHC 
genotypes d/d and k/k (Fig. 3b and d) showed similar patterns 
of susceptibility to Salmonella and TMEV, the reverse of what 
we found in the single-infection experiments (Fig. 2).
This apparent reversal of susceptibility patterns between 
single infections and coinfcctions suggests there is an interac­
tion between these two pathogens during coinfcction and these 
specific MHC genotypes, as seen in other coinfcctions such as 
HIV and many parasitic diseases (19). When wc tested this 
hypothesis, there was not a significant difference in the overall 
pattern of susceptibility (opposite or similar) between single 
infections and coinfcctions (data not shown). However, there 
was no significant difference between the d/d and k/k homozy­
gotes for either the single infections (Fig. 2) or coinfcctions 
(Fig. 3). Thus, for this genotypic combination, wc cannot de­
termine whether the TMEV loads show an opposite or similar
pattern of susceptibility, and so we cxcludcd them from further 
analysis. All patterns seen in single infections and coinfcctions 
(Fig. 2 and 3) arc similar to those seen in previous studies (34, 
43), exccpt the d/k genotypic combination.
Figure 4 compares the results of eight coinfcction groups of 
MHC genotypic combinations showing opposite (reciprocal) 
patterns of susceptibility. These eight experiments represent 
comparisons of two haplotype combinations (b with q plus d 
with q), both sexes, and two independent experiments. The 
pattern of hctcrozygotc superiority was observed for standard­
ized combined pathogen loads in seven of the eight groups 
(P = 0.0024 by binomial distribution, where P  = 1/3). Even if 
wc conservatively excluded the two groups where the hetero­
zygote load was similar to the best homozygote (Fig. 4d and h), 
the pattern of hctcrozygotc superiority is still significant (five 
out of six groups, P  = 0.01 by binomial distribution, where P  = 
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FIG. 3. Salmonella and TM EV loads for coinfecled mice of either opposite or similar susceptibility profiles. Pathogen loads are given for 
coinfected female (a) and male (c) animals of different M IIC heterozygote combinations showing opposite susceptibility profiles. Pathogen loads 
are given for coinfected female (b) and male (d) animals of different M IIC heterozygote combinations showing similar susceptibility profiles. In 
the case of opposite susceptibility profiles (a and c). all homozygotes were significantly different (P < 0.05 by t test), except TM EV loads for the 
b/b and q/q genotypic combinations in males (P =  0.07). and resistance was dominant (pathogen loads of heterozygotes were more like the resistant 
than the susceptible homozygote). In the case of similar susceptibility profiles, all homozygotes were significantly different (P < 0.05 by t test) for 
the Salmonella infection but not for the TM EV infection (P >  0.60). Sample sizes are indicated above each bar.
pathogen load in heterozygotes was 41 % lower than the load in 
homozygotes (P = 0.01, by the Wilcoxon rank-sum test).
To estimate the relative strength that each genotypic com­
bination contributed to the overall significant pattern of het­
erozygote superiority (Fig. 4), we pooled the standardized data 
across sex and experiments for each genotype. Figure 5 illus­
trates the standardized combined pathogen loads for the ge­
notypic combinations showing opposite (Fig. 5a and b) and 
similar (Fig. 5c) susceptibility profiles. For opposite suscepti­
bility profiles, the b with q haplotypic combinations showed the 
largest effect, with pathogen loads of the b/q heterozygotes
approximately 71 % lower than those of both the bib and q/q 
homozygotes (P <  0.0001 and P = 0.04, respectively, by the 
Wilcoxon rank-sum test) (Fig. 5a). The d  and q genotypic 
combination (Fig. 5b) showed a nonsignificant pattern of het­
erozygote superiority, and the relative strength was smaller 
than that of b and q, with pathogen loads of the d/q heterozy­
gote being 9% lower than those of d/d homozygotes and 20% 
lower than those of q/q homozygotes. When the MHC geno­
typic combination showing similar patterns of susceptibility 
was examined, MHC f/k heterozygotes were worse than both 
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FIG. 4. Standardized combined pathogen loads for animals show­
ing opposite susceptibility profiles. W e calculated the combined patho­
gen load from the individual Salmonella and TM EV loads for the two 
different genotypic combinations showing opposite susceptibility pro­
files, b/q (a, c, e, and g) and d/q (b, d, f, and h). This was done for two 
independent experiments and for each sex. Sample sizes are indicated 
above each bar.
to the susceptibility being dominant for the Salmonella infec­
tion (Fig. 3b and d).
We used pathogen load as a measure of host immunocom- 
petence due to its strong inverse correlation with overall host 
fitness (e.g., HIV) (41). We tested the effects of MHC geno­
type on death and weight, but no significant differences were 
found (data not shown). These infections were generally be­
nign, with these young, growing animals gaining weight during 
the infection, although at a slower rate than their uninfected 
siblings (data not shown).
DISCUSSION
This is the first experimental evidence for MHC heterozy­
gote superiority, a pathogen-mediated mechanism that could 
contribute to the evolution of MHC diversity. A pattern of
MHC heterozygote superiority was seen in 7 out of 8 compar­
isons (P = 0.0024) (Fig. 4), and the mean standardized load of 
the heterozygotes was 41% lower than the mean of the ho­
mozygotes (P = 0.01). The pooled data also showed a signifi­
cant pattern of heterozygote superiority for the b/q genotypic 
combination (Fig. 5). The negative-control combination o f /  
and k haplotypes did not show a heterozygote superiority pat­
tern. This control excludes the alternative hypothesis that 
MHC heterozygotes have a general advantage under all coin­
fections, as would be the case if the basis of MHC heterozygote 
superiority were the presentation of more peptide antigens.
For the DIHS hypothesis to be a general explanation (at 
least in part) for MHC diversity, the infections experienced 
over the lifetimes of individuals must in general lead to het­
erozygote superiority. This requires two relationships. First, 
MHC heterozygotes must be superior in dealing with infec­
tions separated in time, as this will be more common than 
coinfections. While our experiments used simultaneous dual 
infections, there are no a priori reasons that multiple infections 
separated in time would not also lead to heterozygote superi­
ority. The combined pathogen load, although occurring over a 
longer time period, would still be expected to be lower for 
heterozygotes. Second, the susceptibility and resistance pat­
terns of host MHC alleles to natural pathogens must be some­
what balanced or the worst alleles will become extinct (28). A 
recent survey of MHC-dependent susceptibility and resistance 
patterns across a number of pathogens shows that any given 
haplotype tends to be resistant to some infectious agents and 
susceptible to others (37). Whether these two relationships are 
generally true is an empirical question and remains to be 
tested.
Simulation models demonstrate that symmetrical heterozy­
gote superiority (where fitness of heterozygotes is greater than 
that of homozygotes and all homozygotes and heterozygotes 
have equal lifetime fitnesses within these two genotypic 
classes) is a powerful diversity-maintaining force that can ac­
count for MHC diversity (46). The degree of asymmetry that 
can be tolerated and still maintain MHC diversity is more 
controversial (19, 28). This study provides evidence for the 
hypothesis that heterozygote superiority can emerge under 
conditions where resistance is dominant and susceptibility pro­
files are opposite, which are commonly observed (37) (Table 
1). However, determining whether heterozygote superiority 
emerges under the variety of pathogens experienced in the wild 
will be difficult, as it will require measuring lifetime fitness.
Observational evidence for heterozygote advantage (which 
may or may not be due to heterozygote superiority) (38) has 
been reported for HIV (8) and hepatitis B virus (47) in hu­
mans. Although these studies found heterozygote advantage 
for single infections, the specific pathogens involved can emu­
late a multiple infection. Both HIV (40, 42) and hepatitis B 
virus (23) are polymorphic infections due to mutations that 
accumulate rapidly during chronic infection. Also, both HIV 
(30) and hepatitis B virus (5) have been shown to escape 
MHC-dependent immune recognition, so it is possible that 
some of these polymorphisms could contain viral variants that 
would create opposite susceptibility profiles in MHC-heterozy- 
gous hosts. Both studies propose that MHC heterozygotes had 
an advantage because they present more viral epitopes, or as 
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FIG. 5. Pooled standardized combined pathogen loads for geno­
typic combinations showing opposite (a and b) and similar (c) suscep­
tibility profiles. The sexes and both experiments were pooled for the 
b/q and dlq combinations (a and b). All P  values shown are from a 
Wilcoxon rank-sum test. Sample sizes are indicated above each bar.
the cscapc of MHC-dcpcndcnt immune recognition. The 
DIHS hypothesis provides a new way to explain both the HIV 
and hepatitis B results. However, since both studies only com­
pared heterozygotes to the means of homozygotes, their results 
may simply be hctcrozygotc advantage and not hctcrozygotc 
superiority (36, 38), a result cxpcctcd simply by MHC resis­
tance being dominant over susceptibility (Table I).
Simulation models demonstrate that small levels of (sym­
metrical) hctcrozygotc superiority (approximately I %) arc suf­
ficient to explain the observed levels of MHC genetic diversity 
(44, 46). It is generally impossible to obtain sample sizes with 
vertebrates to statistically demonstrate a I % effect, which may 
explain why MHC hctcrozygotc superiority has been so hard to 
find in previous studies (21). The 9 to 20% effect found for the 
cl and q genotypic combination was not significant by itself (Fig. 
5), but when combined with the b and q genotypic combina­
tion, it contributed to the significance of overall hctcrozygotc
superiority (Fig. 4). The fact that both genotypic combinations 
showing opposite susceptibility profiles in this study were con­
siderably larger than I % is not too surprising bccausc the I % 
requirement applies to the combined effects of all pathogens 
over a lifetime. Any pathogen pair and genotypic combination 
that might show a large effect will be countered by other 
pathogen or genotypic combinations showing small or opposite 
effects.
This is the first experimental evidence for MHC hctcrozy­
gotc superiority under coinfcction, a mechanism that could 
explain (at least in part) the divergence of MHC genes and the 
maintenance of high levels of allelic diversity found in nature. 
The excess of MHC heterozygotes found in some natural pop­
ulations is consistent with such a mechanism (20). However, 
these results do not exclude other proposed mechanisms of 
selection for MHC diversity such as pathogen evasion, auto­
immunity, mating preferences or other reproductive mecha­
nisms (2, 19). Any or all of them may be more important than 
hctcrozygotc superiority. Future studies will be required to 
evaluate the relative importance of these proposed evolution­
ary forces for diversifying MHC genes and the functional sig­
nificance these polymorphisms have on vertebrate immunity.
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